ZA201605666B - Pyrazolo[1,5-a]pyrimidines as antiviral compounds - Google Patents
Pyrazolo[1,5-a]pyrimidines as antiviral compoundsInfo
- Publication number
- ZA201605666B ZA201605666B ZA2016/05666A ZA201605666A ZA201605666B ZA 201605666 B ZA201605666 B ZA 201605666B ZA 2016/05666 A ZA2016/05666 A ZA 2016/05666A ZA 201605666 A ZA201605666 A ZA 201605666A ZA 201605666 B ZA201605666 B ZA 201605666B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyrazolo
- pyrimidines
- antiviral compounds
- antiviral
- compounds
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14152202 | 2014-01-22 | ||
| PCT/EP2015/051177 WO2015110491A2 (en) | 2014-01-22 | 2015-01-21 | Pyrazolo[1,5-a]pyrimidin-7-amine derivatives useful in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201605666B true ZA201605666B (en) | 2021-01-27 |
Family
ID=49989585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2016/05666A ZA201605666B (en) | 2014-01-22 | 2016-08-16 | Pyrazolo[1,5-a]pyrimidines as antiviral compounds |
Country Status (11)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018248581B2 (en) * | 2017-04-05 | 2022-05-26 | Curovir Ab | Heteroaromatic compounds useful in therapy |
| US11649238B2 (en) | 2018-01-17 | 2023-05-16 | Glaxosmithkline Intellectual Property Development Limited | Substituted pyrazolo[1,5-a]pyrimidines as PI4K inhibitors |
| CN108727386A (zh) * | 2018-07-16 | 2018-11-02 | 广州医科大学 | 一种吡唑并嘧啶类化合物及其制备方法和用途 |
| MX2020013039A (es) | 2018-08-21 | 2021-02-26 | Kyorin Seiyaku Kk | Derivado de anillo heteroaromatico biciclico. |
| IL281956B2 (en) * | 2018-10-10 | 2024-07-01 | Curovir Ab | 2,6-DIMETHYL-N-((PYRIDlN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N- [(PYRIDlN-4-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDlN-7-AMINE DERIVATIVES FOR TREATING VIRAL INFECTIONS |
| WO2020074160A1 (en) | 2018-10-10 | 2020-04-16 | Curovir Ab | Condensed pyrimidine or pyridazine derivatives as antiviral agents |
| CN109988172B (zh) * | 2019-01-10 | 2020-09-29 | 石家庄学院 | 一种吡唑并[1,5-a]嘧啶类杂环化合物及衍生物的合成方法 |
| EP4028131B1 (en) | 2019-08-20 | 2023-11-22 | Curovir Ab | Heteroaromatic compounds useful in therapy |
| WO2024184442A1 (en) | 2023-03-09 | 2024-09-12 | Curovir Ab | Compound and formulation for systemic therapy by oral transmucosal administration |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2585462B2 (ja) * | 1989-10-25 | 1997-02-26 | 株式会社大塚製薬工場 | ピラゾロ［１，５―ａ］ピリミジン誘導体 |
| DE69130683T2 (de) * | 1991-04-22 | 1999-05-06 | Otsuka Pharmaceutical Factory, Inc., Naruto, Tokushima | PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL |
| US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| CA2379585C (en) * | 1999-09-30 | 2006-06-20 | James W. Darrow | Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| JP2005529919A (ja) * | 2002-05-10 | 2005-10-06 | スミスクライン ビーチャム コーポレーション | 治療用化合物 |
| US7601724B2 (en) * | 2002-09-04 | 2009-10-13 | Schering Corporation | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| JP4790265B2 (ja) * | 2002-09-04 | 2011-10-12 | シェーリング コーポレイション | サイクリン依存性キナーゼインヒビターとしての新規ピラゾロピリミジン |
| GB0519957D0 (en) * | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
| WO2010086040A1 (en) * | 2009-01-29 | 2010-08-05 | Biomarin Iga, Ltd. | Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy |
| EP2539342B1 (en) * | 2010-02-26 | 2015-04-15 | Mitsubishi Tanabe Pharma Corporation | Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| US8633198B1 (en) * | 2011-09-20 | 2014-01-21 | Nant Holdings Ip, Llc | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
-
2015
- 2015-01-21 CA CA2935658A patent/CA2935658C/en active Active
- 2015-01-21 AU AU2015208205A patent/AU2015208205B2/en active Active
- 2015-01-21 JP JP2016548033A patent/JP6509238B2/ja active Active
- 2015-01-21 RU RU2016134130A patent/RU2689788C2/ru active
- 2015-01-21 US US15/107,930 patent/US9963455B2/en active Active
- 2015-01-21 WO PCT/EP2015/051177 patent/WO2015110491A2/en active Application Filing
- 2015-01-21 BR BR112016016798-8A patent/BR112016016798B1/pt active IP Right Grant
- 2015-01-21 ES ES15702990T patent/ES2954126T3/es active Active
- 2015-01-21 CN CN201580005612.2A patent/CN106061975B/zh active Active
- 2015-01-21 EP EP15702990.1A patent/EP3096762B1/en active Active
-
2016
- 2016-08-16 ZA ZA2016/05666A patent/ZA201605666B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015110491A2 (en) | 2015-07-30 |
| US9963455B2 (en) | 2018-05-08 |
| JP2017503830A (ja) | 2017-02-02 |
| EP3096762A2 (en) | 2016-11-30 |
| WO2015110491A3 (en) | 2015-09-17 |
| RU2016134130A (ru) | 2018-02-26 |
| CA2935658A1 (en) | 2015-07-30 |
| CN106061975B (zh) | 2019-09-24 |
| RU2689788C2 (ru) | 2019-05-29 |
| RU2016134130A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2018-08-30 |
| BR112016016798B1 (pt) | 2022-06-28 |
| BR112016016798A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2017-08-08 |
| JP6509238B2 (ja) | 2019-05-08 |
| AU2015208205B2 (en) | 2019-12-05 |
| CN106061975A (zh) | 2016-10-26 |
| EP3096762B1 (en) | 2023-06-28 |
| NZ722290A (en) | 2021-08-27 |
| ES2954126T3 (es) | 2023-11-20 |
| US20160318937A1 (en) | 2016-11-03 |
| AU2015208205A1 (en) | 2016-08-18 |
| EP3096762C0 (en) | 2023-06-28 |
| CA2935658C (en) | 2023-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259169A (en) | Novel pyrazolo pyrimidine derivatives | |
| IL254224A0 (en) | 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors | |
| IL260923B (en) | History of pyrazolo[5,1-a]pyrazin-4-yl as jak inhibitors | |
| PL3345907T3 (pl) | Związki pirazolo[3,4-d]pirymidynowe lub ich sole | |
| ZA201802842B (en) | [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound | |
| ZA201506570B (en) | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents | |
| IL266305B (en) | History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors | |
| ZA201707320B (en) | Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds | |
| IL243092A0 (en) | New triazolo[d–4,5]pyrimidine histories | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| PL3129374T3 (pl) | (5,6-Dihydro)pirymido[4,5-e]indolizyny | |
| IL262673A (en) | A pyrazolo[5,1-a]pyrimidine compound | |
| HUE060733T2 (hu) | Pirrolo[2,3-d]pirimidin vegyület vagy annak sója | |
| EP3227292A4 (en) | 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS | |
| HUE050298T2 (hu) | Pirazolo[3,4-D]pirimidin vegyületek vagy annak sói | |
| HK1240222A1 (en) | 4h-pyrido[1,2-a]pyrimidin-4-one compounds | |
| AU2014904868A0 (en) | 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS | |
| TH1601001194A (th) | อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่ |